Vincenzo Silani is a Professor of Neurology who holds a Chair in Neurology at the University of Milan Medical School in Italy. He is Director of the Department of Neurology-Stroke Unit and the Laboratory of Neuroscience at the IRCCS Istituto Auxologico Italiano, Director of the “Dino Ferrari”Center for Neuromuscular and Neurodegenerative Diseases of the University of Milan Medical School, and Member of the Center for Brain Experimental Therapeutics and Neurotechnology at the same University.
After receiving his medical degree cum laude from the University of Milan Medical School, Dr. Silani completed a felloship in neuroscience (Dr. Stanley H. Appel) at the Department of Neurology of the Baylor College of Medicine in Houston. He then completed the residency program both in Neurology and Neurosurgery cum laude in Milan. Prof. Silani’s research pursuits lie in neurodegenerative diseases affecting motor neurons: a genetic program has been developed for ALS/FTD, the search of biomarkers developed, and iCPs obtained from patients (Biobanking). He has been a principle investigator on numerous drug trials concerning treatment options for the disease.
He is Member of the American Academy of Neurology (AAN), European Academy of Neurology (EAN) (appointed as FEAN in 2016), Society of Neuroscience USA, and Italian Society of Neurology. He is Chairman of the Italian Consortium for Genetics in ALS (SLAGEN) and since 2013 Co-Chairman dell’European Academy of Neurology (EAN) Subspeciality Panel ALS and Frontotemporal Dementia. He is Member of the NEALS Consortium (2017).